FDA Drug Recalls

Recalls / Class II

Class IID-0203-2021

Product

neostigmine methylsulfate 5 mg/5 mL, (1mg/ml), Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004075009

Affected lot / code info
Lot # 1220023044, BUD 1/30/2021

Why it was recalled

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Recalling firm

Firm
SCA Pharmaceuticals
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
755 Rainbow Rd Ste B, Windsor, Connecticut 06095-1024

Distribution

Quantity
390 syringes
Distribution pattern
Product was distributed to hospitals nationwide.

Timeline

Recall initiated
2020-12-17
FDA classified
2021-01-07
Posted by FDA
2021-01-13
Terminated
2021-11-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0203-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.